Nvidia Eyes $10 Billion Investment in Anthropic IPO 
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision 
Central Banks Could Buy 20,000 Tonnes of Gold: BofA 
Fitch Eyes Japan Budget for Fiscal Discipline 
Huawei, Chinese AI Chipmakers Raise Prices as HBM Shortage Bites 
White House Weighs Refined Copper Tariffs as Cost Concerns Grow 
UK Economy Grows 0.4% in July, Beating Forecasts 
Gold Prices Rebound as Dollar Weakens, Fed Decision Looms 
Norway Core Inflation Rises to 3% in August 
Brent Oil Tops $100 as Middle East Conflict Threatens Supply 
Kioxia Rules Out SK Hynix Manufacturing Partnership 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
ECB Rate Hike in Focus as Oil Tops $100 
Trump Signs Order to Cut Routine Childhood Vaccines 
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise 
Iraq Seeks 6 Million Bpd OPEC+ Oil Quota 
Add as a preferred source on Google
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
